Immuron Ltd. Files Form 6-K Reporting Publication

TL;DR

Immuron Ltd. filed a 6-K on July 15, 2024, reporting a publication. No specific details on the publication were provided in this filing.

AI Summary

On July 15, 2024, Immuron Ltd. filed a Form 6-K to report a publication. The filing does not contain specific financial figures or dates for the publication itself, but it indicates that the company is a foreign private issuer based in Australia and files reports under the 1934 Act.

Why It Matters

This filing serves as a notification to the SEC about a published announcement by Immuron Ltd., a foreign private issuer, which may contain important updates for investors.

Risk Assessment

Risk Level: low — The filing is a routine notification of a publication and does not contain new financial data or significant operational changes.

Key Players & Entities

• Immuron Ltd. (company) — Registrant
• 001-38104 (company) — SEC File Number
• July 2024 (date) — Reporting Period
• July 15, 2024 (date) — Filing Date

FAQ

Filing Documents

• ea0209417-6k_immuron.htm (6-K) — 13KB
• ea020941701ex99-1_immuron.htm (EX-99.1) — 18KB
• ex99-1_001.jpg (GRAPHIC) — 10KB
• ex99-1_002.jpg (GRAPHIC) — 3KB
• ex99-1_003.jpg (GRAPHIC) — 33KB
• 0001213900-24-061171.txt ( ) — 97KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on July 15, 2024 titled: - “Immuron Travelan record sales globally, Australia and USA” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron Travelan record sales globally, Australia and USA 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: July 15, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR